Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304408 · ClinicalTrials.gov registry record
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody
A clinical trial, sponsored by Michael E. DeBakey VA Medical Center.
- Completed
- Registry status
- 10
- Enrollment target
NCT00304408 is a clinical trial that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT00304408 has completed, sponsored by Michael E. DeBakey VA Medical Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is three fold: 1)To collect serum from patients with documented Clostridium difficile infection and test for the presence of antibody to C. difficile toxin at the start and at the end of therapy, and again if a relapse or recurrence occurs. 2)To collect stool samples for test of C. difficile toxin at similar time intervals. 3)To assay random serum samples from the VA lab in order to determine the rate of antibody to C. difficile toxin in our patient population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00304408
The ClinicalTrials.gov registry entry for NCT00304408 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael E. DeBakey VA Medical Center, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00304408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00304408 about?
NCT00304408 is a clinical study titled "Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody". The purpose of this study is three fold: 1)To collect serum from patients with documented Clostridium difficile infection and test for the presence of antibody to C. difficile toxin at the start and at the end of therapy, and again if a relapse or recurrence occurs. 2)To collect stool samples for te...
What is the current status of trial NCT00304408?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2005-01. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00304408?
This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.